HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The risk of optic atrophy following suramin treatment of ocular onchocerciasis.

Abstract
Treatment of onchocerciasis with suramin in an area of vector control led to an increased incidence of optic atrophy in treated patients compared to an untreated group.
AuthorsB Thylefors, A Rolland
JournalBulletin of the World Health Organization (Bull World Health Organ) Vol. 57 Issue 3 Pg. 479-80 ( 1979) ISSN: 0042-9686 [Print] Switzerland
PMID314359 (Publication Type: Journal Article)
Chemical References
  • Suramin
Topics
  • Eye Diseases (drug therapy)
  • Female
  • Humans
  • Male
  • Onchocerciasis (drug therapy)
  • Optic Atrophy (chemically induced)
  • Suramin (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: